News
The Schwabe Group invests in good schools
For nearly 15 years, the Schwabe Group has supported education projects for young people in southern Africa with the Umckaloabo Foundation, which was founded by Schwabe in 2010. The secondary school in Makululu, Zambia, has just been expanded.
“European mini-gardeners” at Terra Medica – learning about organic gardening
15 “European mini-gardeners” came to Terra Medica, where the Schwabe Group grows medicinal plants outside Karlsruhe, rolled up their sleeves to take part in different aspects of work the organic garden and even harvested lavender, camphor basil and calendula.
Schwabe City Cycling Team - Thank you for biking 26,700 kilometers
In July, our team “Schwabe – From Nature. For Health.” took part in the three-week City Cycling event hosted by the Karlsruhe municipal government, and in that time we covered almost 27,000 kilometers – almost 17,000 miles! Our team alone saved nearly 4,439 tons of CO2 emissions!
Schwabe Group awards research prizes at important Phyto Congress
At the International Congress on Natural Product Research in Krakow, the Schwabe Group presented the Dr. Willmar Schwabe Award and the Dr. Willmar Schwabe Young Talent Prize to two female scientists from Indonesia and Hong Kong, respectively.
EGb 761® recommended for the treatment of mental problems caused by long COVID
In a recently published long COVID review, the authors present recommendations for GP care based on a systematic literature review and personal therapeutic experience: EGb® 761 is recommended for the treatment of mental problems caused by long COVID.
A milestone in phytomedicine: clinical trial proves efficacy of Silexan® in depression
A recent publication reports on our international clinical trial to demonstrate the efficacy and safety of Silexan®, a proprietary lavender oil preparation, in the treatment of mild to moderate depressive episodes.
Schwabe Group now top sponsor of important natural-product research congress
The Schwabe Group together with Bayer has become the silver sponsor of the International Congress on Natural Products Research. The congress is organized by seven independent professional societies from America, Asia and Europe. It brings together more than 1,000 scientists from all over the world.
Umckaloabo Foundation: We are helping our “Little Five” get bigger!
The Umckaloabo Foundation has set itself the goal of giving children and young people in southern Africa a future with prospects and a self-determined life through sustainable, successful educational projects. This year the Umckaloabo Foundation is helping five elementary schools in the Eastern Cape.
Treatment with EPs® 7630 reduces illness absence from childcare due to acute bronchitis
Recently, a meta-analysis was published which considered and analyzed the available randomized, placebo-controlled clinical trials with EPs® 7630 in children and adolescents. The question was to what extent treatment with EPs® 7630 for acute bronchitis reduces the average time of illness absence from kindergarten, school, or training.
14.02.2023 - A clinical trial assessed the use of EPs® 7630 as Syrup and Solution in children ages one to five with acute bronchitis. The study found that an improvement in health status and complaints were comparably positive in treatment with EPs® 7630. Both dosage forms were equally safe and well-tolerated in children between the ages of one and five.
26.01.2023 - In 2022, the Schwabe Group Germany converted to green electricity at both of its sites in Karlsruhe. This means that all of the electricity obtained from our power supplier comes from renewable kinds of energy.
15.01.2023 - We are pleased to announce a new research agreement with Dalhousie University from Nova Scotia, Canada. In conjunction with Prof. Vasantha Rupasinghe, one of the leading experts in the field of research about the haskap berry, we will analyze novel extraction methods for producing a special extract with enriched active substances (cyanidin-3-glucoside).
05.12.2022 - We are pleased to announce that our high-quality pharmaceutical Refluthin® was launched in Belgium. New Refluthin® chewable tablets have twice the effect on heartburn: the mineral-based acid buffers quickly soothe acid-related gastric discomfort such as heartburn and acid regurgitation.
21.11.2022 - Our Web Content Management System (WCMS) is one of the winners of this year's SplashAwards. In the category "Healthcare", the Schwabe Group came out as the best Drupal project..
16.11.2022 - Schwabe Group Germany received an award this year once again for its commitment to offering professional training! The business magazine Capital gave us full marks in the fields of mentorship, innovative teaching methods, and excellent future prospects!
13.10.2022 - For over 10 years Nature’s Way has been quietly supporting Feed the Children – a non-profit organization which envisions a world in which no child goes to bed hungry.
16.09.202 - The Dr Willmar Schwabe Award, which is sponsored by our company, was first presented by the GA – Society for Medicinal Plant and Natural Product Research, one of the world’s most important scientific societies in phytoresearch, back in 1961. This year Dr Simone Moser from Ludwig Maximilian University of Munich, was awarded for her innovative and pioneering research.
14.09.2022 - At the 39th Annual Healthcare Advertising Award ceremony, Schwabe’s explainer video on the topic of mild cognitive impairment (MCI) won over the jury and brought home a Merit Award.
25.08.2022 - The Pegaso® line consists of probiotics, prebiotics, herbal ingredients and vitamins, and it represents a distinctive therapeutic approach to specific GI complaints (diarrhea, constipation, etc.). At the same time, it is ideal for treating a variety of problems in children and adults.
29.07.2022 - In a recent review, Bartova et al.* present findings that Silexan® has beneficial effects also on co-occurring depressive symptoms in patients with underlying anxiety and anxiety disorders. The data were collected from patients with anxiety in several clinical trials and have now been recompiled and statistically analyzed.
08.06.2022 - As part of the Schwabe Phyto Innovation Challenge, we are pleased to announce a new research agreement with the department of pharmacognosy at the University of Vienna. Under the guidance of chair Dr. Judith M. Rollinger, we will spend the next three years working on a joint project to analyze the positive effects of herbal extracts and combinations of natural substances on age-related diseases.
07.07.2022 - As part of the Schwabe Phyto Innovation Challenge, we have now successfully launched a collaborative project: Dr. Simone Moser and her team will analyze phylloxanthobilins; this group of substances was discovered in recent years and is thought to have potentially positive effects on arteriosclerosis. The process of the blood vessels hardening is responsible for the majority of cardiovascular problems in older people.
13.04.2022 - We are pleased to announce that our high-quality pharmaceutical Gaspan® was launched in Italy. Recurrent or persistent gastrointestinal complaints such as flatulence, mild cramps and a feeling of fullness impair quality of life. Gaspan® works with a unique combination of peppermint oil and caraway oil and has a targeted effect where the discomfort is caused: in the gut.